Literature DB >> 34535814

Preparation of magnetic yolk-shell structured metal-organic framework material and its application in pharmacokinetics study of alkaloids.

Shi-Jun Yin1, Xu Wang1, Hui Jiang1, Min Lu1, Xi Zhou1, Li-Xian Li2, Feng-Qing Yang3.   

Abstract

In this study, a magnetic yolk-shell structured metal-organic framework material (Fe3O4@YS-UiO-66-NH2) is prepared by the directional etching of Co2+/peroxymonosulfate and in situ magnetization. The characteristic properties of the material were investigated by using field emission scanning electron microscopy, transmission electron microscopy, energy-dispersive X-ray spectroscopy, X-ray powder diffraction, Fourier transform infrared spectroscopy, vibrating sample magnetometer, Brunauer-Emmett-Teller, and contact angle test. The Fe3O4@YS-UiO-66-NH2 shows the advantages of large surface area, good magnetic property, and satisfactory stability, as well as giving high affinity to alkaloids (ALs) via hydrophilic interaction, hydrogen bonding, and π-π interaction. The results of static adsorption experiment indicate that the Fe3O4@YS-UiO-66-NH2 possesses high adsorption capacity towards ALs and the adsorption behaviors are fitted with Langmuir adsorption isotherm model. Furthermore, a magnetic solid-phase extraction using Fe3O4@YS-UiO-66-NH2 and HPLC method was developed for the analysis of ALs in spiked samples with the recovery of 89.6-100.8%. In addition, the proposed method was successfully applied in the pharmacokinetics study of berberine, coptisine, and palmatine in the rat. In short, the developed method might be used for high-efficient recognition and determination of ALs in plasma sample, which would also provide a new way to fabricate magnetic functionalized metal-organic framework in separation science.
© 2021. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Alkaloids; Magnetic solid-phase extraction; Metal-organic framework; Pharmacokinetics; Yolk-shell structure

Mesh:

Substances:

Year:  2021        PMID: 34535814     DOI: 10.1007/s00216-021-03656-2

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  25 in total

1.  Determination of berberine in pharmaceutical preparations using acidic hydrogen peroxide-nitrite chemiluminescence system.

Authors:  Yao-Dong Liang; Chun-Xia Yu
Journal:  Drug Test Anal       Date:  2011-04-16       Impact factor: 3.345

2.  The anti-hyperglycemia effects of Rhizoma Coptidis alkaloids: A systematic review of modern pharmacological studies of the traditional herbal medicine.

Authors:  Hang Ma; Kai He; Jianwei Zhu; Xuegang Li; Xiaoli Ye
Journal:  Fitoterapia       Date:  2019-03-02       Impact factor: 2.882

Review 3.  Pharmacokinetic properties, potential herb-drug interactions and acute toxicity of oral Rhizoma coptidis alkaloids.

Authors:  Bing-Liang Ma; Yue-Ming Ma
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-09-24       Impact factor: 4.481

4.  Online preconcentration by electrokinetic supercharging for sensitive determination of berberine and jatrorrhizine in biological samples.

Authors:  Chu Chu; Linmin Lian; Caijing Liu; Jing Li; Hui Mao; Luyi Jiang; Jizhong Yan
Journal:  Biomed Chromatogr       Date:  2020-03-18       Impact factor: 1.902

5.  Pharmacological and safety evaluation of fibrous root of Rhizoma Coptidis.

Authors:  Na Ning; Yan Zhi Wang; Zong Yao Zou; De Zhou Zhang; De Zhen Wang; Xue Gang Li
Journal:  Environ Toxicol Pharmacol       Date:  2014-11-15       Impact factor: 4.860

6.  Metabolic profile of Rhizoma coptidis in human plasma determined using ultra-high-performance liquid chromatography coupled with high-resolution mass spectrometry.

Authors:  Qing-Shan Zhang; Gao-Wa Wang; Zhi-Qiang Han; Xiang-Mei Chen; Risu Na; Haburi Jin; Ping Li; Renbatu Bu
Journal:  Rapid Commun Mass Spectrom       Date:  2018-01-15       Impact factor: 2.419

7.  Metabolism of Rhizoma coptidis in Human Urine by Ultra-High-Performance Liquid Chromatography Coupled with High-Resolution Mass Spectrometry.

Authors:  Qingshan Zhang; Gaowa Wang; Xi Chen; Zhiqiang Han; Xiangmei Chen; Risu Na; Haburi Jin; Ping Li; Renbatu Bu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-08       Impact factor: 2.441

Review 8.  Coptidis Rhizoma: a comprehensive review of its traditional uses, botany, phytochemistry, pharmacology and toxicology.

Authors:  Jin Wang; Lin Wang; Guan-Hua Lou; Hai-Rong Zeng; Ju Hu; Qin-Wan Huang; Wei Peng; Xiang-Bo Yang
Journal:  Pharm Biol       Date:  2019-12       Impact factor: 3.503

9.  Significant pharmacokinetic differences of berberine are attributable to variations in gut microbiota between Africans and Chinese.

Authors:  Raphael N Alolga; Yong Fan; Zhuo Chen; Li-Wei Liu; Yi-Jing Zhao; Jin Li; Yan Chen; Mao-De Lai; Ping Li; Lian-Wen Qi
Journal:  Sci Rep       Date:  2016-06-10       Impact factor: 4.379

Review 10.  Coptidis rhizoma and its main bioactive components: recent advances in chemical investigation, quality evaluation and pharmacological activity.

Authors:  Fan-Cheng Meng; Zheng-Feng Wu; Zhi-Qi Yin; Li-Gen Lin; Ruibing Wang; Qing-Wen Zhang
Journal:  Chin Med       Date:  2018-03-07       Impact factor: 5.455

View more
  1 in total

1.  Carbonized π-conjugated polymer-coated porous silica: preparation and evaluating its extraction ability for berberine.

Authors:  Pian Jin; Fucheng Zhu; Mi Jiang; Makoto Takafuji; Hirotaka Ihara; Lei Nie; Houmei Liu
Journal:  Mikrochim Acta       Date:  2022-10-03       Impact factor: 6.408

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.